Paper21995808
A prospective study of infantile hemangiomas with a focus on incidence and risk factors.
Dickison P and 2 others. Pediatr Dermatol, 2011. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Papers, record 21995808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21995808
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemangioma, Capillary | Major topic |
| Neoplastic Syndromes, Hereditary | Major topic |
| Skin Neoplasms | Major topic |
| Australia | |
| Female | |
| Fertilization in Vitro | |
| Follow-Up Studies | |
| Gestational Age | |
| Humans | |
| Incidence | |
| Infant | |
| Infant, Low Birth Weight | |
| Infant, Newborn | |
| Male | |
| Prospective Studies | |
| Risk Factors | |
| Sex Factors |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42848308 | Ulcerated infantile hemangioma in the β-blocker era: recent advances. | World J Pediatr | 2026 | https://conductscience.org/library/papers/42848308 | PubMed |
| 42638276 | Influencing Factors Associated With Infantile Hemangioma: A Case-Control Study Among Chinese Pediatric Populations. | J Dermatol | 2026 | https://conductscience.org/library/papers/42638276 | PubMed |
| 41860115 | Risk Factors for Airway Infantile Hemangioma. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/41860115 | PubMed |
| 41236230 | Unveiling Infantile Hemangiomas: A Comprehensive Study of Patterns, Presentations, and Complications. | Dermatol Pract Concept | 2025 | https://conductscience.org/library/papers/41236230 | PubMed |
| 40729252 | Infantile Hemangioma: Risk Factors and Management in a Preterm Patient-A Case Report. | Reports (MDPI) | 2024 | https://conductscience.org/library/papers/40729252 | PubMed |
| 39935564 | Nanotechnology in Infantile Hemangioma Management. | J Pediatr Pharmacol Ther | 2025 | https://conductscience.org/library/papers/39935564 | PubMed |
| 39822455 | Optimizing Propranolol Therapy for Infantile Hemangiomas: The Role of the Multidisciplinary Team. | Cureus | 2024 | https://conductscience.org/library/papers/39822455 | PubMed |
| 39594972 | Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review. | Children (Basel) | 2024 | https://conductscience.org/library/papers/39594972 | PubMed |
| 39394137 | Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring: an umbrella review of systematic reviews with meta-analyses of observational studies. | BMC Med | 2024 | https://conductscience.org/library/papers/39394137 | PubMed |
| 39286286 | Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39286286 | PubMed |
| 39253065 | Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma. | Clin Cosmet Investig Dermatol | 2024 | https://conductscience.org/library/papers/39253065 | PubMed |
| 38279335 | Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38279335 | PubMed |
| 38228125 | Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents. | Dermatology | 2024 | https://conductscience.org/library/papers/38228125 | PubMed |
| 38158419 | Recent updates in laryngeal hemangioma management: a scoping review. | Eur Arch Otorhinolaryngol | 2024 | https://conductscience.org/library/papers/38158419 | PubMed |
| 37795158 | Overview of the Head and Neck Hemangiomas: a 5-year Retrospective Study. | Mater Sociomed | 2023 | https://conductscience.org/library/papers/37795158 | PubMed |
| 37763272 | Infantile Hemangioma: A Cross-Sectional Observational Study. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37763272 | PubMed |
| 37649330 | Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers. | Acta Derm Venereol | 2023 | https://conductscience.org/library/papers/37649330 | PubMed |
| 37632184 | A retrospective 10 years- experience overview of dye laser treatments for vascular pathologies. | Skin Res Technol | 2023 | https://conductscience.org/library/papers/37632184 | PubMed |
| 37628313 | Infantile Haemangioma in the Romanian Paediatric Population-Characteristics and Therapeutic Approaches. | Children (Basel) | 2023 | https://conductscience.org/library/papers/37628313 | PubMed |
| 37588830 | Validation of a Quality of Life Assessment Questionnaire for Patients with Infantile Hemangioma and Their Families - the IH-QOL-RO. | Maedica (Bucur) | 2023 | https://conductscience.org/library/papers/37588830 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21995808
GET https://conductscience.org/api/papers/v1/21995808/cited_by?page=2